ConductScience.org, home

Paper10850488

Regulatory T cells: key controllers of immunologic self-tolerance.

Sakaguchi S. Cell, 2000. Cited by 1,283 papers, by iCite.

Cite this record

ConductScience Library. Regulatory T cells: key controllers of immunologic self-tolerance. Papers, record 10850488. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10850488

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Regulatory T cells: key controllers of immunologic self-tolerance.
PubMed
Journal
Cell
PubMed
Year
2000
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
1,283
iCite
Relative citation ratio, by iCite
23.3
iCite
Revised in PubMed
2024-01-09
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sakaguchi SS

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Self ToleranceMajor topic
T-LymphocytesMajor topic
Animals
CD4-Positive T-Lymphocytes
Cytokines
Forecasting
Humans
Thymus Gland

Source PubMed

Download CSV of topics

Cited by554

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,283 citations.

PMIDTitleJournalYearIn PapersSource
42939708Effectiveness of Native and Enhanced Extracellular Vesicle Preparations Assessed in Animal Models of Multiple Sclerosis: A Meta-Analysis.Biomolecules2026https://conductscience.org/library/papers/42939708PubMed
42787555NLRP3-mediated pyroptosis in cardiovascular disease: from molecular mechanisms to therapeutic targets.Front Pharmacol2026https://conductscience.org/library/papers/42787555PubMed
42755835Thirty years in, regulatory T cells are ready for medicine.Front Immunol2026https://conductscience.org/library/papers/42755835PubMed
42619433Impact of Chronic Infection-Induced Inflammation on TREG Cell Homeostasis.Eur J Immunol2026https://conductscience.org/library/papers/42619433PubMed
42603165Regulatory T cells: From Foxp3 to tolerance-inducing therapies.J Invest Dermatol2026https://conductscience.org/library/papers/42603165PubMed
42511524Immune Cytolytic Activity Correlates with Tumor Microenvironmental Aberrations in Colorectal Cancer.Int J Mol Sci2026https://conductscience.org/library/papers/42511524PubMed
42466984Ligand-Blocking and Agonist Antibodies Targeting TNFR2 Use Distinct Modes of Action to Induce Antitumor Immunity.Cancer Res2026https://conductscience.org/library/papers/42466984PubMed
42309733Seminal fluid effects on female reproductive function in laboratory, livestock, and domestic species.J Reprod Dev2026https://conductscience.org/library/papers/42309733PubMed
42280844CD4+ T Lymphocytes-From Their Multiple Immunological Roles to New Sensing Strategies Using Marine Magnetotactic Bacteria-A Systematic Review.Sensors (Basel)2026https://conductscience.org/library/papers/42280844PubMed
42079184Defects in CD8+ T cell suppression by Foxp3-ΔE2 expressing regulatory T cells.bioRxiv2026https://conductscience.org/library/papers/42079184PubMed
42021888[Research Progress of Peripheral Immune Tolerance in Oral Diseases].Sichuan Da Xue Xue Bao Yi Xue Ban2026https://conductscience.org/library/papers/42021888PubMed
41737211OX40 signaling in cancer immunotherapy: mechanisms of action, translational applications, and therapeutic perspectives.Front Immunol2026https://conductscience.org/library/papers/41737211PubMed
41731059Targeting immunometabolism for the treatment of diabetic cardiomyopathy.Nat Cardiovasc Res2026https://conductscience.org/library/papers/41731059PubMed
41536671[Targeting Regulatory T Cells to Remodel Peripheral Immune Tolerance: Research Advances and Future Directions].Sichuan Da Xue Xue Bao Yi Xue Ban2025https://conductscience.org/library/papers/41536671PubMed
41424385IKAROS regulates human T cell phenotype at a thymic and postthymic level.JCI Insight2025https://conductscience.org/library/papers/41424385PubMed
41368312Nonclinical regulatory considerations for investigational new drug applications for regulatory T cell therapies.Front Med (Lausanne)2025https://conductscience.org/library/papers/41368312PubMed
41328153Molecular Therapy Advances: Building the bridge between discovery and cure.Mol Ther Methods Clin Dev2025https://conductscience.org/library/papers/41328153PubMed
41136446The impact of PANoptosis-related genes on immune profiles and subtype classification in ischemic stroke.Sci Rep2025https://conductscience.org/library/papers/41136446PubMed
41032161The Targets of Immune Adverse Events in Cancer Immunotherapy by Combined Check-point Inhibitors Resemble those Seen in IPEX Patients.J Clin Immunol2025https://conductscience.org/library/papers/41032161PubMed
40961368Spices to Combat Sepsis: Curcumin and Piperine Combination Increases Survival and Modulates Immune Response in a Murine Two-Hit Trauma Model.Shock2026https://conductscience.org/library/papers/40961368PubMed

See all 554 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/10850488

GET https://conductscience.org/api/papers/v1/10850488/cited_by?page=2